Jing Xu

5.6k total citations · 1 hit paper
152 papers, 4.0k citations indexed

About

Jing Xu is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jing Xu has authored 152 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 29 papers in Oncology and 26 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jing Xu's work include Lung Cancer Treatments and Mutations (8 papers), Endoplasmic Reticulum Stress and Disease (6 papers) and COVID-19 Clinical Research Studies (6 papers). Jing Xu is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Endoplasmic Reticulum Stress and Disease (6 papers) and COVID-19 Clinical Research Studies (6 papers). Jing Xu collaborates with scholars based in China, United States and Italy. Jing Xu's co-authors include Jun O. Liu, Yongjun Dang, Zhibiao Wang, Yunzhao R. Ren, Chenglai Fu, Solomon H. Snyder, Curtis R. Chong, Luis F. Parada, Feng Rao and Shridhar Bhat and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Jing Xu

135 papers receiving 3.9k citations

Hit Papers

Plasma phospho‐tau181 increases with Alzheimer's disease ... 2018 2026 2020 2023 2018 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Plasma phospho‐tau181 increases with Alzheimer's disease clinical severity and is associated with tau‐ and amyloid‐positron emission tomography
    2018 413 citations Jing Xu et al. profile →

Peers

Jing Xu
Fuu‐Jen Tsai Taiwan
Xiaohua Chen China
Jianli Wang China
Ying Liu China
Mark D. Johnson United States
Karl Kashofer Austria
Lucio Pastore Italy
Jue Wang China
Giulia d’Amati Italy
Wei‐Chiao Chang Taiwan
Fuu‐Jen Tsai Taiwan
Jing Xu
Citations per year, relative to Jing Xu Jing Xu (= 1×) peers Fuu‐Jen Tsai

Countries citing papers authored by Jing Xu

Since Specialization
Citations

This map shows the geographic impact of Jing Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Xu more than expected).

Fields of papers citing papers by Jing Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Xu. The network helps show where Jing Xu may publish in the future.

Co-authorship network of co-authors of Jing Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Xu. A scholar is included among the top collaborators of Jing Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Xu. Jing Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Jinling, Jing Xu, Ning Jiang, et al.. (2024). Case report: A rare case of hereditary hemochromatosis caused by a mutation in the HAMP gene in Fuyang, China. Frontiers in Medicine. 11. 1417611–1417611.
3.
Xu, Jing, et al.. (2024). A phase I trial of autologous RAK cell immunotherapy in metastatic renal cell carcinoma. Cancer Immunology Immunotherapy. 73(6). 107–107. 1 indexed citations
4.
Zhou, Xiaoli, et al.. (2023). Ergonomic evaluation of thermal comfort for different outlet distribution patterns and ventilation conditions in the pilot protective helmet. Applied Thermal Engineering. 226. 120355–120355. 3 indexed citations
5.
Qian, Yawei, Yi Liu, Zichen Wang, et al.. (2023). Investigation of the Causal Relationship Between Alcohol Consumption and COVID-19: A Two-Sample Mendelian Randomization Study. International Journal of Computational Intelligence Systems. 16(1). 2 indexed citations
6.
7.
Ni, Yuanli, Jing Xu, & Dali Tong. (2023). Targeting the JMJD6/TGF-β axis in prostate cancer by immunotherapy: A potential treatment based on RNA splicing. Medical Hypotheses. 171. 111018–111018.
8.
Zhu, Ling, Jing Xu, Xu Zhu, et al.. (2023). ASSOCIATIONS OF METAL EXPOSURE WITH HYPERURICEMIA AND GOUT IN GENERAL ADULTS. Journal of the American College of Cardiology. 81(8). 1720–1720. 1 indexed citations
9.
Shi, Lianjie, et al.. (2023). Elevated serum soluble CD27 levels are associated with both disease activity and humoral immune activity in patients with rheumatoid arthritis. Clinical and Experimental Rheumatology. 42(5). 983–990. 1 indexed citations
10.
11.
12.
13.
Yao, Jincao, Wenwen Yue, Wei Li, et al.. (2022). DeepThy‐Net: A Multimodal Deep Learning Method for Predicting Cervical Lymph Node Metastasis in Papillary Thyroid Cancer. SHILAP Revista de lepidopterología. 4(10). 33 indexed citations
14.
Xu, Jing, et al.. (2022). Maternal blood inflammatory marker levels increased in fetuses with ventriculomegaly. Frontiers in Human Neuroscience. 16. 998206–998206. 3 indexed citations
15.
Yang, Shaoxing, Jing Xu, Panpan Lv, et al.. (2022). Efficacy of different sequential patterns after crizotinib progression in advanced anaplastic lymphoma kinase‐positive non–small cell lung cancer. Thoracic Cancer. 13(12). 1788–1794. 3 indexed citations
16.
Narasimhan, Madhusudhanan, Lenin Mahimainathan, Ellen Araj, et al.. (2021). Clinical Evaluation of the Abbott Alinity SARS-CoV-2 Spike-Specific Quantitative IgG and IgM Assays among Infected, Recovered, and Vaccinated Groups. Journal of Clinical Microbiology. 59(7). e0038821–e0038821. 80 indexed citations
17.
Vail, Eric, Jianbo Song, Jing Xu, et al.. (2020). Comparison of Large, Medium, and Small Solid Tumor Gene Panels for Detection of Clinically Actionable Mutations in Cancer. Targeted Oncology. 15(4). 523–530. 9 indexed citations
18.
Huang, Hsin‐Yi, Wenjing Zhang, Yijun Gao, et al.. (2017). YAP Suppresses Lung Squamous Cell Carcinoma Progression via Deregulation of the DNp63–GPX2 Axis and ROS Accumulation. Cancer Research. 77(21). 5769–5781. 68 indexed citations
19.
Rao, Feng, Jing Xu, Chenglai Fu, et al.. (2015). Inositol pyrophosphates promote tumor growth and metastasis by antagonizing liver kinase B1. Proceedings of the National Academy of Sciences. 112(6). 1773–1778. 78 indexed citations
20.
Johnson, D. Gale, Hong Jiang, Jing Xu, et al.. (2007). Transgenic E2F1 Expression in the Mouse Brain Induces a Human-Like Bimodal Pattern of Tumors. Cancer Research. 67(9). 4005–4009. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fuu‐Jen Tsai Breakdown of academic impact, for papers by Xiaohua Chen Breakdown of academic impact, for papers by Jianli Wang Breakdown of academic impact, for papers by Ying Liu Breakdown of academic impact, for papers by Mark D. Johnson Breakdown of academic impact, for papers by Karl Kashofer Breakdown of academic impact, for papers by Lucio Pastore Breakdown of academic impact, for papers by Jue Wang Breakdown of academic impact, for papers by Giulia d’Amati Breakdown of academic impact, for papers by Wei‐Chiao Chang
Rankless by CCL
2026